Literature DB >> 7994851

Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats.

B I Levy1, M Duriez, M Phillipe, P Poitevin, J B Michel.   

Abstract

BACKGROUND: The effect of genetic hypertension and of chronic therapy by calcium entry blocker (CEB, isradipine) on the function and structure of large arteries has been studied in adult spontaneously hypertensive rats (SHR, n = 30) and in their normotensive control Wistar-Kyoto (WKY) rats (n = 30). METHODS AND
RESULTS: Fifteen-week-old rats were randomly allocated to treatment with isradipine (3 mg/kg subcutaneously once a day) or to placebo and followed for 12 weeks. Hemodynamic parameters, including instantaneous pressure and aortic velocity, were recorded under anesthesia at the end of the treatment period. Passive mechanical properties of carotid arteries were measured in situ in the presence or the absence of smooth muscle cell activity (potassium cyanide poisoning). Histomorphometric parameters of the carotid and aortic media, including cross-sectional area, medial thickness, nucleus density and size, and medial contents of proteins of interstitial matrix, were measured by an automated morphometric system. Untreated SHRs had greater peripheral resistance, stiffer and thicker arterial walls because of smooth muscle cell hyperplasia (thoracic aorta and carotid artery) and/or hypertrophy (thoracic aorta), and increased collagen content than did normotensive control rats. SHRs showed a significant left ventricular hypertrophy. For the whole duration of treatment, treatment with CEB normalized the arterial pressure in SHRs. We observed a significant decrease in peripheral resistance, increased cardiac output, and left ventricular contractility without significant reduction in left ventricular hypertrophy. Increases in diuresis and natriuresis were associated during the last week of treatment in both treated strains with marked increase in plasma renin activity; in contrast, urinary aldosterone was increased by treatment in WKY rats but not in SHRs. Arterial compliance was significantly increased by CEB under control and passive conditions. CEB induced a significant reduction in the medial hypertrophy of the aortic walls of SHRs and WKY rats associated with a reduction in medial hyperplasia. In the carotid artery, CEB reduced smooth muscle cell hypertrophy but did not affect the smooth muscle cell hyperplasia. Isradipine significantly reduced the arterial wall collagen contents in both strains, with marked increases in the elastin content in the carotid but not in the aortic wall.
CONCLUSIONS: These results suggest that (1) despite normalization of arterial pressure, chronic treatment with CEB in SHRs does not significantly reduce left ventricular hypertrophy, probably because of increase in myocardial contractility and/or increase in plasma renin activity; (2) mechanical properties of the arterial wall are normalized by treatment; and (3) remodeling of the arterial wall by CEB is not uniform according to the studied vessel.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994851     DOI: 10.1161/01.cir.90.6.3024

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Mechanisms underlying Eugenia mattosii D. Legrand leaves extract, fractions and compounds induce relaxation of the aorta from normotensive and hypertensive rats.

Authors:  Giovana Vechi; Priscila de Souza; Luísa Mota da Silva; Sérgio Faloni de Andrade; Valdir Cechinel Filho; Rita de Cássia Melo Vilhena de Andrade Fonseca Da Silva
Journal:  3 Biotech       Date:  2019-11-11       Impact factor: 2.406

2.  Influence of graded changes in vasomotor tone on the carotid arterial mechanics in live spontaneously hypertensive rats.

Authors:  P Lacolley; N Ghodsi; E Glazer; P Challande; A M Brissac; M E Safar; S Laurent
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

3.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

Authors:  Z M Bhujwalla; D Artemov; K Natarajan; E Ackerstaff; M Solaiyappan
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

4.  Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.

Authors:  B Corman; M Duriez; P Poitevin; D Heudes; P Bruneval; A Tedgui; B I Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.

Authors:  B I Levy; J Benessiano; D Henrion; L Caputo; C Heymes; M Duriez; P Poitevin; J L Samuel
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Time courses of growth and remodeling of porcine aortic media during hypertension: a quantitative immunohistochemical examination.

Authors:  Jin-Jia Hu; Andy Ambrus; Theresa W Fossum; Matthew W Miller; Jay D Humphrey; Emily Wilson
Journal:  J Histochem Cytochem       Date:  2007-12-10       Impact factor: 2.479

7.  Beneficial effects of C36, a novel breaker of advanced glycation endproducts cross-links, on the cardiovascular system of diabetic rats.

Authors:  G Cheng; L-L Wang; L Long; H-Y Liu; H Cui; W-S Qu; S Li
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 8.  Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

9.  Resistive and pulsatile arterial hemodynamics and cardiovascular events: the Multiethnic Study of Atherosclerosis.

Authors:  Scott M Lilly; David Jacobs; David A Bluemke; Daniel Duprez; Payman Zamani; Julio Chirinos
Journal:  J Am Heart Assoc       Date:  2014-12-11       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.